Kalos Management’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-10,500
| Closed | -$21K | – | 134 |
|
|
2022
Q2 | $21K | Hold |
10,500
| – | – | 0.03% | 133 |
|
|
2022
Q1 | $21K | Sell |
10,500
-14,570
| -58% | -$29.1K | 0.01% | 173 |
|
|
2021
Q4 | $110K | Buy |
25,070
+2,070
| +9% | +$9.08K | 0.03% | 278 |
|
|
2021
Q3 | $101K | Sell |
23,000
-750
| -3% | -$3.29K | 0.03% | 280 |
|
|
2021
Q2 | $130K | Hold |
23,750
| – | – | 0.05% | 249 |
|
|
2021
Q1 | $155K | Hold |
23,750
| – | – | 0.05% | 274 |
|
|
2020
Q4 | $114K | Sell |
23,750
-500
| -2% | -$2.4K | 0.05% | 236 |
|
|
2020
Q3 | $141K | Buy |
24,250
+200
| +0.8% | +$1.16K | 0.06% | 212 |
|
|
2020
Q2 | $162K | Buy |
24,050
+5,500
| +30% | +$37K | 0.07% | 195 |
|
|
2020
Q1 | $119K | Buy |
18,550
+7,500
| +68% | +$48.1K | 0.05% | 185 |
|
|
2019
Q4 | $114K | Buy |
+11,050
| New | +$114K | 0.04% | 189 |
|